2023環境
、社會及管治報告康龍化成（北京）新藥技術股份有限公司
1.1.16
1.2.ESG20
1.3.25
1.4.30
2.1.36
2.2.43
2.3.43
2.4.46
3.1.52
3.2.55
3.3.63
3.4.66
12030
3 ESG
4 GRI
4.1.70
4.2.80
4.3.84
5.1.90
5.2.100
5.3.106
6.1.112
6.2.112
(ESG)20231120231231
GRI(GRI standards)MSCI ESGESG
ESG
ESGESG
2023
2023
ESG2023
20232023
2023
2023
(Reaction of the Day)20239
2023
(TCFD)
2024
2024
ESGESGESGESGESG
ESGESG
ESGESG ESG
ESGESGESG
ESG
ESG2023ESG2024327
2023
300759.SZ/3759.HK
CMC
CDMO
CMC, Chemistry, Manufacture and ControlCMC
CDMO, Contract Development and Manufacturing Organization
ADC, Antibody-drug Conjugate
CADD, Computer-Aided Drug Design
?ADC
(CADD
)
2023
CMCCDMO
?
/
TQT/
CRC
SSU
IND
APIActive Pharmaceutical Ingredient
cGMP, Current Good Manufacture PracticesFDA
ICH, The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
FDA, Food and Drug Administration
NNPA, National Medical Products Administration
EMA, European Medicines Agency
TQTQT/QTc
CRC, Clinical Research Coordinator
SSU, Study Start up
IND, Investigational new drugIND
? CMCCDMO
linkerPayload
CMCCDMO
cGMP
(ICH
Guidelines)FDA
NMPA
EMA
cGMP
?
(CDMO)
(CDMO)
CDMO
200L2,000LDNARNA
GLP
/GCP
/GMP
CDMO
GMPcGMPCDMO
IIIIII
MHRA
GLP, Good Laboratory PracticeGLP
GCP, Good Clinical Practice
GMP, Good Manufacturing Practice
MHRA, Medicines and Healthcare Products Regulatory Agency
2023
2023
? A
? Sustainalytics
2023ESG
? EcoVadis
? CDP B
? MSCI ESG BBB
? S&P DJSI (CSA) ESG45
?
202310088
? 202310067 202310033
?
? 202317 50
? 2023ESG
? 500 50061
? 50 2023ESG TOP 50
? 2023 CDMOTOP 10
?
? CRO CRO
? 2023 2023
? Moka2023
? 2023Top50
? 2023
2023
> 1,153,799.63
12.39%
> ISO20000ISO 27001
ESG
> 20ESG>
>>>
2023
>
6,897.17>
ISO 14001> 100%
>
490.44
>20,295
54.67%
> 3
> 11> 2023491 11
>44,827
58.78%
ESG
2023
11932436%44%
20%
2023? 1ESG<>
?
(Science Based Targetsinitiative, SBTi
)
Ambitious corporate climate action – Science Based Targets(CDP)(UNGC)
(WRI)(WWF)
????
2023
60%
????
2023
????2023
2022
2023
ESG
ESG
????
???
2023ESGPSCI2022
ESG
2023
ESG
ESGESGESGESG
ESG
ESG
ESGESG
ESG
ESGESG
ESG
ESG
ESGESG
ESGESGESG
ESG
ESG
ESG
EHS
ESG
2023
ESG
ESGESGEHSESG
? ESG? ESG? ESG? ESG? ESG? ESG
ESG? ESGESGESG? ESGESGESG? ESG? ESG? ESGESG
ESG
? ESGESG? ESGESG? ESG? ESGESG
? ESGESG
ESG
ESG
?????
????
????
???
???
????
???
?
???
?ESG
??
?? ?? ? ESG????
?
2023
GRI(GRIstandards)MSCIESGESG
20ESG2023ESGESG
ESG
2023ESG
ESG
2023
1.2.
40-50
51-60
>60
2023
(D&I)D&I
???
D&I
???
???
Employee Resources Groups (ERGs) and Governance)
ERGERG
D&I(Employee Resource GroupERG)
ERGERG
ERG
2023
(Recruitment and Selection Policy)(Anti-Harassment and Bullying Policy)(Equal Opportunities Policy)
2023
2023%54.67%45.47%45.95%23.33
%53.47STEMSTEM%55.57
%91.91
%8.09
%86.36
%1.68
%0.68
%0.66
%0.60
%0.44
%0.42
%0.11
%0.09
%0.87
%5.55
%2.22
IT
? STEMSTEM???
2023
2023
2023
7,032
3,0264,7842,248
Foreign Corrupt PracticesActFCPA2010(UK Bribery Act2010)2023
???
?
(FCPA)2010(UKBA)???
???
?? ESG?
??
2023
2023
2023
2023
100%
? ??? ?
2023%100
4,669
%100
compliance@pharmaron.com
2023
(EudraLex)
(Food, Drug and Cosmetics Act)
(CIOMS)
(EudraLex)
(Federal Food, Drug and Cosmetics Act)
? ?
????
???
? (SOP
)?
SOP, Standard Operating Procedure
(SOP)
2023
IT
24QA
19862021Animals (Scientific Procedures) Act 1986, amended 2021(Animal Welfare Act)
(IACUC
)
(IACUC)
IACUC, Institutional Animal Care and Use Committee
??
????
? 11?
(IACUC)
2023
??????
?? IACUC
????
IACUCIACUC
IACUC
IACUC
IACUC
(AAALACInternational
)(PHS
Animal Welfare Assurance)2023
AAALAC, International, Association for Assessment and Accreditation of Laboratory Animal Care, International
PHS, U.S. Public Health Service
20239
3300
98%
2023
(3R
)
(Replacement)(Reduction)(Refinement)
?
2023ETS123
GB14925-2010?? 20237178
????
???
3R
2023
ITIT
IT
IT
2023
2023
2023ISO 20000ISO 27001
2023
2023
ESG
2023
2023
AF454
20232023
100%
PSCI
ESG
EHS(Contractor or Service Provider EHS AssessmentQuestionnaire)
2023
100%
2023
EHS2023Chemical Industries Association
20232
2023ESG
RED2GREENRedbox
998.9GiftTrees11171
GiftTrees
ESGISO 140003C
2010GMP202207ICH Q7(GMP)(GLP)
(GCP)GCP(EudraLex)4 GMP21 CFR 210ICH Q8ICH Q9ICH Q10
ICH Q11NMPA202012;FDAcGMPMHRAMHRA GxP21 CFR 112020(EudraLex)7
?
?
?
?
GMP
GMP
?
2023
(FDA)(EMA)(NMPA)GMP
ISO 13485ISO 9001ISO 9001
202320232024CAPA
ISO 13485ISO 9001
SME
ICHQ7GMPICH Q10GMPGMPGMPGCPGLPCMCGMPGCPGLP
QP
SMESubject Expert
CLIA CertificateCOLA AccreditationMaryland State Non-expiring Laboratory PermitState of MarylandRadioactive Material LicenseState of Maryland Pharmacy LicensePharmacy CDS LicensePharmacy DEA License
QP (Qualified Person)
100%
QP
?GMP
?CROISO 13485
?SMOISO 9001
?CPCCLIA CertificateCOLA Accreditation
2023
CMC GMPGMPGLPGCP
SOP
SOP
100%
100%
?
CADDGMP
GMP
202344,82716,595.3158.78%
2023
44,827
16,595.31
58.78%
2023
?
2018AMSADME DMPK
/ADME
DMPK? POC
IND
?
IIIIIIIV
DMPK, Drug Metabolism Pharmacokinetic(ADME)
ADME, Absorption Distribution Metabolism And Excretion
POC, Proof of Concept
IND
CRO
? IND
IND
ICHGLP/GCP/GMP
GMPNMPAFDAOECD GLP
IND
2023
(AI)
(AI)
? AI? AI
? AI? AI
??
?
? ?
? ?
AIDD
ADMET
AIFEP
AIDD, Artificial Intelligence for Drug Discovery, AI
ADMET, AbsorptionDistributionMetabolismExcretionToxicity
FEP, Free Energy Perturbation
2023AIDDADMET AIFEPADMET AIFEP
2023
2023923
3,300
20234
9111
1192
32923
20222023
2023
2023
4,528.04
ISO 45001
ISO 45001
EHS
(JHA)
ISO 45001
EHS
20232023
2023?
?
? 100%
? EHS100%? 0? 0
GB/T 16180-2014
2023
202320222021
%000
9721,377562
EHS
2023EHS
2023
(COA)
57%100%
2023
20231
1996(EmploymentRights Act 1996)(Pay Transparency Non-discrimination Provision)
(Recruitment and Selection Policy)
1.3
?
?
?
?
2023
(DISCIPLINARY PROCEDURE POLICY)
1998
(Children (Protection at Work) Regulations 1998)2004(The Children Act 2004)
(National Labor Relations Act)
2023
2023814
(Succession Plan)
20231434673
HR
2023
2023720100
STEM202314
STEM
2023
202320,2959,20011,095
20,295
303014,42431-50505,65151220
13,8885,436
18,6531,642
4,19416,011%45.47
2023(COE)
(HRBP)(SSC)
2023140.71%
(People Strategy Implementation Roadmap)(People StrategyNewsletter Special Edition)
=
2023
(Learning and Development Policy)
EMBA/MBA
2023
202310294
2023
2023
(Onboarding Program)2023
2023
2023
2023
202322,64719,723633,785.89 %97.18
31.23
%98.22
33.16
%95.92
28.90
%100
26.90
%93.40
25.37
%98.07
32.80
ICH GCP/GCPGVPGLPSOP
2023100%
2023
2023100%2023
(Fair Labor Standards Act)
20233
2023
?
?
?
?
?
?
?
?
?
?Perk Pal
?
?
?
?
?
?
?
?
?
?
? 202312107
4,300
2023
2023L&DNewsletter
202360070%
?400-820-0393?compliance@pharmaron.com
?
2023
86.58%
?
?
? (Mental Health First Aider)
?
?
?
?
1974(Health and safety at Work etc. Act 1974)1995(Occupation Safety and Health)ISO 45001
2023
2023
202391%4431419
Get
PDP
2023
?
? OAEHS
?
?
2023
?
?
?
20236,897.17
202311
(COP28)
(TCFD)
ESG
COP28 https://www.un.org/climatechange/cop28
https://www.un.org/zh/documents/treaty/FCCC -CP-2015-L.9-Rev.1
???
???
??
ESG
2023
(SBTi)CDP (Carbon Disclosure Project)
2022(SBTi)SBTiSBTiSBTi
? 202320331254.6%? 20232033361.1%
? 202320501290%? 20232050397%
? 2023
? 20231.55/
(%)
? 100%
SBTiSBTi
2023
5354
1286.18%270.58%
2023202220212020
10,0001,264.53873.23636.701,847.03
40.7811.989.7213.85
82.0137.8633.8326.3910,00029,425.5723,418.7915,679.0411,306.12
207,050.43111,312.5748,427.17–149,808.51132,771.7491,999.0067,693.00
79,459.3161,341.6041,285.4547,265.72
0.0690.0600.0550.090
+ CO2e251,495.98183,166.48128,641.7690,531.27 + CO2e0.220.180.170.18
CO2e34,755.6819,261.3614,066.229,788.89CO2e216,740.30163,905.13114,575.5480,742.38CO2e395,142.93–––
2004Greenhouse Gas Protocol Corporate Accounting and Reporting Standard
(2004) ghgprotocol.org/sites/default/files/standards/ghg -protocol-revised.pdf
32011Greenhouse Gas Protocol Corporate Value Chain (Scope
3) Accounting and Reporting Standard (2011)3 ghgprotocol.org/sites/default/files/standards/Corporate -Value-Chain-Accounting-Reporing-Standard_041,613_ 2.pdf
2022
2020-2022
2020-2022
2022
2023
SBT
2023
Chemical Industries AssociationCIA
)Environment AgencyEA(Chemical Sector Climate Change Agreement,CCA
)2023Energy Saving Opportunity SchemeESOS
2024
About CIABATA
CCA
#LESS
(My Green Lab
)(SDGs)
? BMS (Building management system)? 800??? 200?? (GWP)
#LESS – Energy & Carbon ( energyandcarbon.co.uk )
My Green Lab
2023
2023
60%30-50%
BMS
500KW
?
?2023
85%90%
100%
2023
2023
EHS
2023
?
??
?
??
?
??
?
? ESG?
?
??
?
?
?
?
?
?
??
?
2023
?
??
?
??
?
??
?
? ESG?
?
??
?
?
?
?
?
?
??
?
ESGEHS
1990(Environmental Protection Act 19902021(Environment Act 2021)(Energy PolicyAct of 2020)2023
??
EHS
?
??
??
2023
ISO 14001
ISO 14001
? OA??
?
? 2,500???
? LEDLED
??? (Building management system, BMS)?
2023
20237.81,20018,000
RTO
SEE2023SEE
2023
2023
20232022202120201,787,904.251,710,203.521,155,027.40820,715.48
1.551.671.551.6016,210.0013,870.0011,170.0044,320.00
0.0140.0140.015–
2023422100%
?? PharmaronEHS Newsletter
? EHS?
1974(Control of Pollution Act 19742011The Waste (Englandand Wales) Regulations 2011(Clean Water Act(Clean Air Act)2023
??
??
?2023
??
2023
2023100%
???
??2023
10%?
?
??
? 2023
?
2023
2023
20232
2023
2005(Control ofnoise at work regulations 2005)(Noise Control Act)
202320222021202038,929,953,297.2831,225,570,734.5919,765,426,359.3213,906,732,802.75
118.1084.3864.3333.00
0.580.260.120.19
12.711.901.341.85
1.710.180.081.36
103.1082.0462.7928.991,179,158.651,054,522.70820,896.50641,003.60
160.81170.4445.4854.53
149.37162.4037.0450.69
3.142.182.643.04
7.804.945.27–
0.500.920.530.806,107.734,778.252,035.043,114.84
0.0050.0050.0030.006
876.69540.12––23,018.8020,210.5715,569.548,432.59
0.0200.0200.0200.0162,304.331,196.99––
1. 2021
2. 2022
3. 2022
SEE
BiophorumBiophorum
2023
2021
2023SEE2023490.44250
2023
202312186.2
20232
20238
20237
20236200030
+
2023
202372,0002.8
1 20302030(SDGs)SDGs2023
?
?
????
??
?
?
?
2023
????????
????
?
?
?
??
SDGs2023
202320222021202010,0001,264.53873.23636.701,847.03
40.7811.989.7213.85
82.0137.8633.8326.3910,00029,425.5723,418.7915,679.0411,306.12
207,050.43111,312.5748,427.17–
149,808.51132,771.7491,999.0067,693.00
79,459.3161,341.6041,285.4547,265.72
0.0690.0600.0550.090+
CO2e
251,495.98183,166.48128,641.7690,531.27
+
CO2e
0.220.180.170.18CO2e
34,755.6819,261.3614,066.229,788.89CO2e
216,740.30163,905.13114,575.5480,742.38CO2e395,142.93–––
1,787,904.251,710,203.521,155,027.40820,715.48
1.551.671.551.60
16,210.0013,870.0011,170.0044,320.00
0.0140.0140.015–
38,929,953,297.2831,225,570,734.5919,765,426,359.3213,906,732,802.75
118.1084.3864.3333.00
0.580.260.120.19
12.711.901.341.85
1.710.180.081.36
103.1082.0462.7928.99
2023
1,179,158.651,054,522.70820,896.50641,003.60
160.81170.4445.4854.53
149.37162.4037.0450.69
3.142.182.643.04
7.804.945.27–
0.500.920.530.806,107.734,778.252,035.043,114.84
0.0050.0050.0030.006
876.69540.12––2,437.68578.58––1,838.2265.32––
936.290.22––
876.69540.12––
18.576.66––
–3,587.352,035.043,114.8423,018.8020,210.5715,569.548,432.59
0.0200.0200.0200.0162,304.331,196.99––12,916.458,888.32––
11.63308.59–––33.33––2,304.331,196.99––3,503.261,046.51––
6.45127.25––3,218.602,889.15––
1,058.095,720.4315,569.548,432.59
20222022ESG20212020
20222022ESG20212020
2023202220212020
202320222021202020,29519,48114,92311,0799,2009,0577,0935,55011,09510,4247,8305,46220,29519,45914,90611,012
221767303014,42413,92810,2027,19631-50505,6515,3424,5483,69051220211173126
13,88813,78910,6067,450
5,4364,8103,647–971882670–18,65317,89613,773–
1,6421,5851,150–
909287684,1943,6152,8621,92516,01115,77411,9749,019161131––%18.15–––%54.6753.5152.4749.30%45.4744.59––%45.95–––
%23.33–––
%53.47–––STEMSTEM
%55.57–––
%91.91–––
%8.09–––
2023
2023
%86.36––/%1.68––/%0.68––/%0.66––/%0.60––/%0.44––/%0.42––/%0.11––/%0.09––/%0.87––/%5.55––/
%2.22–––
3.41–––
2.50–––2,869–––%14.1414.61––
1,291–––
%14.0312.81––
1,578–––
%14.2216.15––302,381–––30%16.5115.67––31-50462–––31-50%8.1811.66––5126–––51%11.8217.54––
2,638–––
%14.1414.45––
118–––113–––
%14.0716.21––
2,638–––
%13.0014.43––3468–––3%2.31–––3423–––3%2.08–––
2023202220212020
22,64711,7352,62127019,723–119,128–%97.1896.4897.94100.00
633,785.89635,479.56943,116.50–
31.2332.6263.27–%98.2296.9699.92100.00
33.1628.8053.0217.32%95.9294.6798.67100.00
28.9037.0274.6014.86%100.0075.0061.90100.00/26.905.078.795.57%93.4093.8647.57100.00
25.3711.6739.5019.02%98.0796.4897.94100.00
32.8037.5869.3415.90%100100––
4,6693,012––
%100100––
7,0324,7313,3322,978
3,0264,7313,332–
4,7842,8482,8572,726
2,2481,88347525220–––
7,012–––4547051,160492
16,149–––
%86.58–––
%100100––
0000%0000
9721,377562514
490.44––471.67
250–––
%140.71–––
2023202220212020
2023
3 ESG
A1(a)(b)
A1.1A1.2
A1.3A1.4A1.5A1.6A2
A2.1A2.2A2.3A2.4A2.5
A3
A3.1A4
A4.1
B1
(a)(b)B1.1B1.2B2(a)(b)B2.1B2.2B2.3B3
B3.1B3.2
2023
B4(a)(b)B4.1B4.2B5B5.1B5.2B5.3B5.4B6(a)(b)B6.1B6.2B6.3B6.4B6.5B7:
(a)(b)B7.1B7.2B7.3B8:
B8.1
B8.2
4 GRI
20231120231231GRIGRIGRI 1GRI 12021GRI 22-12-22-32-42-52-62-72-82-92-102-122-13ESG2-142-152-16ESG2-17ESG2-18ESG2-22ESG2-23ESG2-24ESG2-252-272-29ESG
2023
GRI 320213-1ESG3-2ESG3-3ESGGRI 201201-2201-3GRI 205205-1205-2205-3GRI 206206-1GRI 302302-1302-3302-4302-5GRI 304304-1304-2304-3GRI 305305-11305-22305-4305-5
GRI 401401-2GRI 403403-1403-2403-3403-4403-5403-6403-7403-8403-9403-10GRI 404404-1404-2GRI 405405-1GRI 406406-1GRI 413413-1GRI 414414-1414-2
2023
ICH Q7GMPICH Q8ICH Q9ICH Q10ICH Q11
2010
GMP202207(GLP)(GCP)
GCP2020122020
EudraLexFederal Food, Drug and Cosmetic ActPSCIAnimal Welfare Act
cGMPForeign Corrupt Practices ActFCPAPay Transparency Non-discrimination ProvisionNational Labor Relations ActFair Labor Standards ActOccupation Safety and Health ActEnergy Policy Act of 2020Clean Water ActClean Air ActNoise Control Act2010UK Bribery Act 201019862021AnimalsScientificProcedures Act 1986, amended 2021MHRA GxPMHRA Guidance on GxP DataIntegrity1996Employment Rights Act 19961998ChildrenProtection at Work Regulations19982004The Children Act 20041974Health and safety at Work etc. Act 197419951990Environmental Protection Act 19902021Environment Act 20211974Control of Pollution Act 19742011The WasteEngland and WalesRegulations 2011
2005Control of noise at work regulations 2005
2023
Recruitment and Selection PolicyAnti-Harassment and Bullying PolicyEqual Opportunities Policy
IACUC
People Strategy Implementation RoadmapPeople Strategy Newsletter Special EditionLearning and Development Policy
2023
Pharmaron US, Inc.Pharmaron (Hong Kong) International LimitedPharmaron (Hong Kong) Investments LimitedPharmaron Japan LLCPharmaron (US) Lab Services, Inc.Pharmaron Biologics (UK) Holdings LimitedPharmaron (UK) Investments LimitedPharmaron Manufacturing Services (US) LLCPharmaron (US) Clinical Holdings, Inc.Pharmaron Biologics (HK) Holdings LimitedPharmaron Biologics (US) Holdings,Inc.
Pharmaron UK LimitedQuotient Bioresearch (Radiochemicals) Limited
Pharmaron (Germantown) Lab Services Inc.Pharmaron CPC, Inc.Pharmaron (US) Clinical Services, Inc.
Pharmaron (Exton) Lab Services LLCPharmaron (San Diego) Lab Services LLCPharmaron (Boston) Lab Services LLCPharmaron Biologics (UK) Ltd
Pharmaron Manufacturing Services (UK) Ltd
Pharmaron, Inc.
2023
100176pharmaron@pharmaron.com
A. B. C. D.E. F. G. H. I.J. K. L. M. ESG
A. B.
A. B.
A. B. C. D.5ESG
2023
SGS通
标
| 标 |
标
准
| 准 |
技
术
| 术 |
服
务
| 务 |
有
限
| 限 |
公
司
| 司 |
可
持
| 持 |
续
发
| 发 |
展
活
| 活 |
动
报
| 报 |
告
-康
| 康 |
龙
化
| 化 |
成
（
| （ |
北
京
| 京 |
）
新
| 新 |
药
技
| 技 |
术
股
| 股 |
份
有
| 有 |
限
公
| 公 |
司
（
| （ |
以
下
| 下 |
简
称
| 称 |
“
康
| 康 |
龙
化
| 化 |
成
”
| ” |
）
提
| 提 |
交
的
| 的 |
《
康
| 康 |
龙
化
| 化 |
成
2023年
| 年 |
环
境
| 境 |
、
社
| 社 |
会
及
| 及 |
管
治
| 治 |
（
ESG）
| ） |
报
告
| 告 |
》
查
| 查 |
证
/验
| 验 |
证
的
| 的 |
性
质
| 质 |
和
范
| 范 |
围
SGS通标标准技术服务有限公司（以下简称“SGS”）受康龙化成（北京）新药技术股份有限公司（以下简称“康龙化成”）的委托，对《康龙化成2023年环境、社会及管治（ESG）报告》进行独立验证。验
| 验 |
证
声
| 声 |
明
的
| 的 |
使
用
| 用 |
者
本验证声明意图提供给所有受康龙化成（北京）新药技术股份有限公司的利益相关方。责
| 责 |
任
声
| 声 |
明
康龙化成（北京）新药技术股份有限公司的《康龙化成2023年环境、社会及管治（ESG）报告》中的信息及报告由其治理机构以及康龙化成（北京）新药技术股份有限公司的管理层负责。SGS并未参与该报告任何材料的准备。我们的责任旨在告知所有康龙化成（北京）新药技术股份有限公司的的利益相关方，在以下规定的验证范围内表达对文本、数据、图表和声明的意见。验
| 验 |
证
标
| 标 |
准
、
| 、 |
类
型
| 型 |
与
验
| 验 |
证
等
| 等 |
级
SGS已根据国际公认标准和指南，为ESG&可持续发展报告验证开发了一套规章，包括：
?全球报告倡议组织可持续发展报告标准（GRIStandards）中包含的原则和报告流程：
oGRI1：基础2021，规定了报告信息质量的要求oGRI2：一般披露2021，用于组织说明报告实践和其他组织详情oGRI3：实质性议题2021，用于组织说明其确定实质性议题的过程、实质性议题清单以及每个议题的管理方法?AA1000系列标准和ISAE3000中的验证等级指南本报告的验证依据下列验证标准开展：
验
| 级 | ||
| 验 | ||
证
标
| 标 |
准
验
| 准 | 验 |
证
等
| 等 |
级
ASGS ESG & SRA 验证规章（基于GRI原则与AA1000指南）中度验
级
验
证
| 证 |
范
围
| 围 |
和
报
| 报 |
告
标
| 标 |
准
验证的内容包括评估下列指定绩效信息的质量、准确性和可靠性以及评估报告内容对下列报告标准的遵循情况：
报
| 准 | ||
| 报 | ||
告
标
| 标 |
准
香港联合交易所有限公司《环境、社会及管治报告指引》
GRI （参照）
验
准
验
证
| 证 |
方
法
| 法 |
验证包括验证前调研、现场采访了位于中国北京市经济技术开发区泰河路6号康龙化成（北京）新药技术股份有限公司总部的相关员工，必要时与外部机构和/或利益相关方进行文档和记录审查和确认。
验
证
| 证 |
局
限
| 限 |
性
从独立审计的财务报告中提取的财务数据，并未作为本验证流程的组成部分与来源数据进行核对。本次验证地点为于康龙化成（北京）新药技术股份有限公司所在地北京，未到达其分支机构所在地进行现场验证。本次验证只对相关部门的部分员工进行了访谈和相关资料的查阅，访谈并未涉及到外部利益相关方。
验证声明
独
立
| 立 |
性
与
| 与 |
能
力
| 力 |
声
明
| 明 |
SGS是全球领先的检验、鉴定、测试和认证机构，是公认的质量和诚信的基准。SGS 集团是检验、测试和验证领域的全球领导者，在多个国家/地区开展业务，提供包括管理体系和服务认证在内的服务；质量、环境、社会和道德审核和培训；环境、社会和可持续发展报告验证。SGS申明与康龙化成为完全独立之组织，对该机构、其附属机构和利益相关方不存在偏见和利益冲突。本次验证团队是由具备与此项任务有关的知识、经验和资质的人员组成的，包括注册于CCAA的ISO 9001审核员、ISO14001 审核员、ISO 45001 审核员、ISO37001 审核员、ISO 37301审核员和SGS认可的具备GRI,AA1000等知识的社会责任/ESG报告主任审验员。查
证
| 证 |
/验
证
| 证 |
意
见
| 见 |
基于上述方法论和所进行的验证，《康龙化成2023年环境、社会及管治（ESG）报告》中包含的信息和数据是准确的、可靠的，对康龙化成在2023年度的可持续发展管理活动提供了公正和中肯的陈述，在所有实质性方面都没有出现不按照报告标准编制的情况。结
论
| 论 |
、
发
| 发 |
现
和
| 和 |
建
议
| 议 |
审验团队认为，康龙化成提交的《康龙化成2023年环境、社会及管治（ESG）报告》遵循了《香港联合交易所有限公司证券上市规则》之《环境、社会及管治报告指引》中的引言和强制性披露规定并参照了GRI标准2021。
报
告
| 告 |
原
则
| 则 |
重
要
| 要 |
性
康龙化成在报告中阐述了利益相关方关注议题实质性调研和分析的方法论，通过重要性分析，对相关方关注的环境、社会及治理的影响，进行了重点汇报，满足重要性原则。量
| 量 |
化
康龙化成针对关键定量绩效指标进行了统计和分析，并在报告中概要阐述了其影响和目的。报告对部分关键绩效近三年的数据进行了比较，以便更好地帮助利益相关方对其管理绩效进行评估。平
| 平 |
衡
康龙化成的报告基本上满足了汇报的平衡性原则，将环境、社会及治理议题进行了如实和不偏倚地披露。一
| 一 |
致
性
| 性 |
康龙化成在报告中使用了一致的方法去披露相关议题，包括关键定量绩效指标的统计方法和统计口径，并在报告中进行了适当的备注和解释，以便让利益相关方可以清晰地进行比较。管
理
| 理 |
方
法
| 法 |
康龙化成的报告对《环境、社会及管治报告指引》中的适用议题进行了管理方法披露。一
般
| 般 |
披
露
| 露 |
康龙化成对《环境、社会及管治报告指引》中适用议题的披露符合一般披露的要求。关
键
| 键 |
绩
效
| 效 |
指
标
| 标 |
披
露
| 露 |
康龙化成对《环境、社会及管治报告指引》中适用的经济、环境和社会的关键绩效指标进行了披露。发
现
| 现 |
和
建
| 建 |
议
对于审验过程中发现的良好实践、社会责任活动及其管理过程中的建议，均在社会责任报告验证内部管理报告中进行了描述，并同康龙化成的相关管理部门进行了交流，供其作为持续改进的参考。签
| 签 |
字
：
| ： |
代
表
| 表 |
通
标
| 标 |
标
准
| 准 |
技
术
| 术 |
服
务
| 务 |
有
限
| 限 |
公
司
| 司 |
David XinSr. Director –Business Assurance北
京
| 京 |
市
阜
| 阜 |
成
路
| 路 |
73号
世
| 世 |
纪
裕
| 裕 |
惠
大
| 大 |
厦
16层
| 层 |
2024年
3月
| 月 |
15日
WWW.SGS.COM
2023